Trending Stock News

American Railcar Industries, Inc. (ARII) to pay $0.40 on Dec 22, 2017; Veru (VERU) Shorts Raised By 13.42%

Veru Incorporated (NASDAQ:VERU) had an increase of 13.42% in short interest. VERU’s SI was 397,300 shares in December as released by FINRA. Its up 13.42% from 350,300 shares previously. With 118,500 avg volume, 3 days are for Veru Incorporated (NASDAQ:VERU)’s short sellers to cover VERU’s short positions. It closed at $1.05 lastly. It is down 0.00% since December 6, 2016 and is . It has underperformed by 16.70% the S&P500.

American Railcar Industries, Inc. (NASDAQ:ARII) is expected to pay $0.40 on Dec 22, 2017. $1.60 is the ADY. (NASDAQ:ARII) shareholders before Dec 7, 2017 will receive the $0.40 dividend. American Railcar Industries, Inc.’s current price of $40.71 translates into 0.98% yield. American Railcar Industries, Inc.’s dividend has Dec 8, 2017 as record date. Oct 31, 2017 is the announcement. The stock decreased 1.02% or $0.42 during the last trading session, reaching $40.71. About 66,280 shares traded. American Railcar Industries, Inc. (NASDAQ:ARII) has declined 4.72% since December 6, 2016 and is downtrending. It has underperformed by 21.42% the S&P500.

Veru Inc., a medical therapeutics company, develops, makes, and markets consumer health care products. The company has market cap of $55.87 million. The companyÂ’s pharmaceuticals product portfolio includes Tamsulosin delayed release sachet that is under bioequivalence study for the treatment of benign prostatic hyperplasia; MSS-722, a fixed ratio of trans- and cis-clomiphene citrate isomers, which is under the Phase II clinical trial to treat male infertility caused by testicular dysfunction; APP-944, a zuclomiphene citrate that is under the Phase II clinical trial for the treatment of hot flashes in men on prostate cancer hormonal therapies; and APP-111, an oral tubulin targeting chemotherapy, which is under the preclinical study to treat metastatic prostate, breast, and ovarian cancers, as well as APP-111/112 oral agents that target colchicine binding site of tubulin for the treatment of gout and familial mediterranean fever. It currently has negative earnings. It also provides consumer health and medical devices, including PREBOOST benzocaine wipes for premature ejaculation; and FC2, which is female disposable contraceptive device, as well as FC2 Female Condom for unintended pregnancy and sexually transmitted infections, including HIV/AIDS and the Zika virus.

Among 5 analysts covering American Railcar Industries (NASDAQ:ARII), 1 have Buy rating, 1 Sell and 3 Hold. Therefore 20% are positive. American Railcar Industries has $45 highest and $32.0 lowest target. $40.75’s average target is 0.10% above currents $40.71 stock price. American Railcar Industries had 14 analyst reports since August 4, 2015 according to SRatingsIntel. The stock of American Railcar Industries, Inc. (NASDAQ:ARII) has “Hold” rating given on Wednesday, August 2 by Stifel Nicolaus. The stock of American Railcar Industries, Inc. (NASDAQ:ARII) has “Hold” rating given on Tuesday, September 19 by Stifel Nicolaus. The rating was maintained by Cowen & Co on Tuesday, October 31 with “Buy”. Cowen & Co maintained the shares of ARII in report on Monday, October 16 with “Buy” rating. As per Wednesday, August 12, the company rating was upgraded by Zacks. The rating was downgraded by Standpoint Research to “Hold” on Monday, December 19. The stock has “Buy” rating by Cowen & Co on Wednesday, August 9. Buckingham Research maintained it with “Neutral” rating and $39 target in Wednesday, November 1 report. The firm has “Underweight” rating by BB&T Capital given on Monday, February 22. Stifel Nicolaus maintained the stock with “Hold” rating in Tuesday, November 7 report.

American Railcar Industries, Inc., together with its subsidiaries, creates and makes hopper and tank railcars in North America. The company has market cap of $776.91 million. The firm operates through three divisions: Manufacturing, Railcar Leasing, and Railcar Services. It has a 14.79 P/E ratio. The Manufacturing segment makes hopper railcars for shipping various dry bulk products, such as plastic pellets, as well as high-density products, including cement and sand; and pressure tank and other railcars.

Investors sentiment increased to 0.9 in 2017 Q2. Its up 0.03, from 0.87 in 2017Q1. It increased, as 23 investors sold American Railcar Industries, Inc. shares while 28 reduced holdings. 19 funds opened positions while 27 raised stakes. 17.86 million shares or 2.92% less from 18.40 million shares in 2017Q1 were reported. Tci Wealth Advsrs Inc has invested 0% in American Railcar Industries, Inc. (NASDAQ:ARII). Pub Employees Retirement Association Of Colorado holds 0% of its portfolio in American Railcar Industries, Inc. (NASDAQ:ARII) for 4,463 shares. Morgan Stanley holds 0% in American Railcar Industries, Inc. (NASDAQ:ARII) or 72,456 shares. Amer Int Gru invested 0% in American Railcar Industries, Inc. (NASDAQ:ARII). Aperio Limited Company holds 0% or 14,682 shares in its portfolio. Brandywine Inv Mgmt Lc holds 33,554 shares or 0.01% of its portfolio. Vanguard Group Inc reported 713,661 shares. Ameritas Invest Prtnrs owns 687 shares for 0% of their portfolio. Plante Moran Fin Advsrs Lc has 0% invested in American Railcar Industries, Inc. (NASDAQ:ARII). Susquehanna Int Group Inc Ltd Liability Partnership has 17,141 shares for 0% of their portfolio. Mackenzie Financial invested 0.01% in American Railcar Industries, Inc. (NASDAQ:ARII). Smithfield Trust holds 0.01% of its portfolio in American Railcar Industries, Inc. (NASDAQ:ARII) for 2,500 shares. New York-based D E Shaw & has invested 0% in American Railcar Industries, Inc. (NASDAQ:ARII). Eqis Management Inc accumulated 10,833 shares or 0.02% of the stock. 12,987 were accumulated by Victory Cap Management.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *